from its late-stage trial in the U.S. and Latin America after U.S. health officials earlier this week questioned the accuracy of preliminary data. The U.K.-based drug giant now said its vaccine is 76% effective in protecting against symptomatic cases of virus.
A release issued on Monday reported an efficacy rate of 79%. AstraZeneca reiterated its two-shot regimen was "well tolerated" among participants and no safety concerns were identified.U.S. President Joe Biden replaces his face mask following an Equal Pay Day event in the South Court Auditorium in the Eisenhower Executive Office Building on March 24, 2021 in Washington, DC.
5. WallStreet 'advisers' and mass media: CNBC, Bloomberg have to be very proud for luring clueless retail 'investors' into the biggest StockMarket BUBBLE in history! This is what they are paid for by big corporations - turning retail investors into bagholders!
More good news please(((